Latest market price
3.87
+0.10+2.52%
OverviewShort InterestFilings
AQSTQT23Aquestive Therapeutics, Inc.·NASDAQ
3.87+2.52%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 23, 20264Statement of changes in beneficial ownership
Oct 19, 20268-KCurrent report
Oct 16, 20263Initial statement of beneficial ownership
Oct 16, 20264Statement of changes in beneficial ownership
Oct 15, 20268-KCurrent report
Oct 14, 20268-KCurrent report
Oct 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 07, 2026SC 13GBeneficial ownership statement (passive)
Sep 29, 20268-KCurrent report
Sep 25, 20268-KCurrent report
Sep 17, 20268-KCurrent report
Sep 16, 20264Statement of changes in beneficial ownership
Sep 11, 20264Statement of changes in beneficial ownership
Sep 10, 20264Statement of changes in beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Sep 08, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 11, 202610-QQuarterly report
Aug 11, 20268-KCurrent report
Aug 10, 20268-KCurrent report
Jul 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 17, 20264Statement of changes in beneficial ownership
Jul 09, 2026424B3Prospectus
Jul 08, 2026EFFECTNotice of effectiveness
#1 / 25 of 378
Page
▼
/ 16